MEDLI2 will reduce uncertainty in aeroshell TPS response with the potential to reduce TPS mass by up to 130 kg for a Mars 2020 class mission. MEDLI2 will reduce uncertainty in supersonic aerodynamic predictions with the potential to reduce the landing footprint size by 30%. MEDLI2 fills critical EDL knowledge gaps which represent a technology advancement in EDL. MEDLI2 advances instrumentation development essential for EDL analysis.
Improved understanding of risk and performance leading to the ability to reduce entry mass and reduce size of landed footprint.
|Organizations Performing Work||Role||Type||Location|
|Langley Research Center (LaRC)||Lead Organization||NASA Center||Hampton, Virginia|
|Ames Research Center (ARC)||Supporting Organization||NASA Center||Moffett Field, California|
|Jet Propulsion Laboratory (JPL)||Supporting Organization||NASA Center||Pasadena, California|
|Lockheed Martin Inc.||Supporting Organization||Industry||Palo Alto, California|
|Tavis Corporation||Supporting Organization||Industry|
|Exploration Capabilities||NASA Program|
|Game Changing Development (GCD)||NASA Program|
|Planetary Science||NASA Program|